Oxford coronavirus vaccine produces strong immune response in older adults
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
Building equity into vaccine distribution
Who gets priority? If the pandemic is hitting certain communities harder, can they be adequately supplied with vaccine doses?
A blended educational model for budding business leaders
Today’s world is undergoing momentous changes, and managers are required to be able to grasp the profound nature of change, to anticipate scenarios.
Affordability and efficiency is the future of healthcare
COVID has highlighted the differences in healthcare affordability across the globe, with a glimpse into what the future of medicine could look like if we don’t act.
More than 900,000 UK small businesses ‘at risk’ of failing by early April
A major wave of bankruptcies for UK firms looms as many current business support programmes expire at the end of March and April, according to research published...
Advisory report outlines opportunities for Amsterdam metropolitan region after the COVID crisis
The COVID-crisis has affected Amsterdam and the metropolitan area disproportionally: substantial unemployment, 5-10 months of backlog in children’s education...
Shaping Singapore’s future, together
“My hope is for Singapore to emerge as a fairer, greener, and more equal country, with a much stronger spirit of solidarity and shared purpose.”
Research for the World: new LSE magazine showcases the power of the social sciences
From working to identify the environmental impact of deforestation and improving our understanding of income inequality to the impact of COVID-19 on care homes...
Pope.L’s new exhibition at Neubauer Collegium is shaped by COVID-19
The Neubauer Collegium for Culture and Society has opened My Kingdom for a Title, a new solo exhibition featuring work by Pope. L, an acclaimed artist and scholar in the University of Chicago’s Department of Visual Arts.
Oxford coronavirus vaccine produces strong immune response in older adults
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
- Advertisement -
